Asset Management One Co. Ltd. lowered its position in shares of Express Scripts Holding (NASDAQ:ESRX) by 2.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 951,223 shares of the company’s stock after selling 24,577 shares during the quarter. Asset Management One Co. Ltd. owned approximately 0.17% of Express Scripts worth $60,220,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the stock. Burt Wealth Advisors grew its position in shares of Express Scripts by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the period. CKW Financial Group boosted its stake in Express Scripts by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after acquiring an additional 300 shares during the last quarter. IHT Wealth Management LLC boosted its stake in Express Scripts by 8.1% during the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after acquiring an additional 145 shares during the last quarter. First Personal Financial Services boosted its stake in Express Scripts by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after acquiring an additional 1,400 shares during the last quarter. Finally, FNY Partners Fund LP bought a new position in Express Scripts during the 1st quarter worth approximately $138,000. Institutional investors and hedge funds own 88.28% of the company’s stock.
In other Express Scripts news, VP Christine Houston sold 10,104 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the transaction, the vice president now directly owns 87,400 shares in the company, valued at approximately $6,124,992. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Phyllis S. Anderson sold 643 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. Corporate insiders own 0.68% of the company’s stock.
Express Scripts (NASDAQ:ESRX) last posted its earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting analysts’ consensus estimates of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The firm had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. During the same quarter in the prior year, the business earned $1.74 earnings per share. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. sell-side analysts forecast that Express Scripts Holding will post 7.03 EPS for the current fiscal year.
Express Scripts declared that its Board of Directors has initiated a share repurchase program on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.
Several research analysts recently weighed in on ESRX shares. ValuEngine lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Robert W. Baird reaffirmed a “hold” rating and issued a $56.00 price target on shares of Express Scripts in a research note on Friday, September 1st. Raymond James Financial reaffirmed an “underperform” rating on shares of Express Scripts in a research note on Monday, October 9th. Zacks Investment Research downgraded shares of Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Finally, Deutsche Bank began coverage on shares of Express Scripts in a report on Monday, December 4th. They issued a “buy” rating and a $75.00 price objective on the stock. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $74.65.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://weekherald.com/2017/12/30/asset-management-one-co-ltd-sells-24577-shares-of-express-scripts-holding-company-esrx.html.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.